Literature DB >> 4312066

Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.

J C Perkins, D N Tucker, H L Knopf, R P Wenzel, A Z Kapikian, R M Chanock.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 4312066     DOI: 10.1093/oxfordjournals.aje.a121098

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  41 in total

1.  Cross-protection among feline caliciviruses.

Authors:  C Povey; J Ingersoll
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Studies of rhinoviruses and coronaviruses at the Common Cold Unit, Salisbury, Wiltshire.

Authors:  D A Tyrrell
Journal:  Postgrad Med J       Date:  1979-02       Impact factor: 2.401

3.  Parenthood and host resistance to the common cold.

Authors:  Rodlescia S Sneed; Sheldon Cohen; Ronald B Turner; William J Doyle
Journal:  Psychosom Med       Date:  2012 Jul-Aug       Impact factor: 4.312

4.  Clinical aspects of protective immunity of the respiratory tract.

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1975-12       Impact factor: 9.139

5.  Responses of mice immunized with influenza virus by serosol and parenteral routes.

Authors:  G H Scott; R J Sydiskis
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Vaccine strategies to induce broadly protective immunity to rhinoviruses.

Authors:  Gary R McLean
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

7.  Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection.

Authors:  K A Callow
Journal:  J Hyg (Lond)       Date:  1985-08

8.  The time course of the humoral immune response to rhinovirus infection.

Authors:  W S Barclay; W al-Nakib; P G Higgins; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

9.  The induction of salivary antibodies by topical sensitization with particulate and soluble bacterial immunogens.

Authors:  J L Ebersole; J A Molinari
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

10.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.